NVO | Novo nordisk as - Stock Value & PE Ratio Analysis

3

24

15

Limited Growth

AI analysis rates NVO with a lower value score of 2.
It is mainly due to unstable operating cash flow, along with potential higher debt.
Over the past 3 months, NVO has maintained a consecutive value rating of 2.0, higher than the rating of 3.6 over the past 3 years, indicating noticeable decrease in enterprise value.
Compared to all stocks in the Health Care sector, NVO has a medium value rating.

NVO Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/02/13 (Weekly Update)

NVO Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

NVO Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.91	24.7%	3.4%	85.68B	934%	4.8%	38.3%
2024Q2	0.9	42.9%	-1.1%	71.31B	798.9%	580.4%	29.5%
2023Q4	0.83	29.7%	7.8%	9.38B	20.6%	3.3%	33.3%
2023Q3	0.71	69%	7.6%	9.72B	39.9%	6.2%	38.3%
2023Q2	0.73	69.8%	5.8%	8.29B	38.8%	1.4%	35.8%

Update to 2025/5/7 (Quarterly Update)

NVO Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

NVO Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of NVO from 2007/01 till Now

5590.29%
Cumulative Return: 24.70%
Annual Return: 25.51%
Volatility: 0.97
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 3)